Overall, 90.4% of the T1D patients were positive for at least one autoantibody, the most common being anti-GAD (73%), followed by anti-IA2 (66%) and anti-insulin (28.7%). This evidence concerns the gene GAD1 and type 1 diabetes mellitus.